Journal
/
/
Repression of Multiple Myeloma Cell Growth In Vivo by Single-wall Carbon Nanotube (SWCNT)-delivered MALAT1 Antisense Oligos
JoVE Journal
Cancer Research
A subscription to JoVE is required to view this content.  Sign in or start your free trial.
JoVE Journal Cancer Research
Repression of Multiple Myeloma Cell Growth In Vivo by Single-wall Carbon Nanotube (SWCNT)-delivered MALAT1 Antisense Oligos
DOI:

07:24 min

December 13, 2018

, ,

Chapters

  • 00:04Title
  • 00:56Synthesis of Functionalized SWCNTs
  • 01:53Conjugation of Anti-MALAT1 Gapmer DNA Flanked by 2′-O Modified RNAs to Functionalized SWCNT
  • 02:54Tail Vein Injection of SWCNT-anti-MALAT1
  • 04:14Evaluation of the Disease Progression
  • 05:01Results: SWCNT-anti-MALAT1 Oligonucleotides Successfully Represses Multiple Myeloma Cell Growth
  • 06:51Conclusion

Summary

Automatic Translation

This manuscript describes the synthesis of a single-wall carbon nanotube (SWCNT)-conjugated MALAT1 antisense gapmer DNA oligonucleotide (SWCNT-anti-MALAT1), which demonstrates the reliable delivery of the SWCNT and the potent therapeutic effect of anti-MALAT1 in vitro and in vivo. Methods used for synthesis, modification, conjugation, and injection of SWCNT-anti-MALAT1 are described.

Related Videos

Read Article